2 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Terminated 2 |
Follow Nasal Polyps: new trials by email Literature Review of Nasal Polyps trials Research Report on Nasal Polyps
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety Study of Benralizumab in Patient With Eosinophilic Chronic Rhinosinusitis With Nasal Polyps (ORCHID) Benralizumab 30 mg, Matched placebo - Nasal Polyposis, Eosinophilic Chronic Rhinosinusitis | Phase 3 | Terminated | AstraZeneca | 295 | 2019-11-25 | 2026-02-19 |
| Mometasone vs Budesonide in CRS With Polyposis Budesonide 0.5 MG/ML, Mometasone nasal spray - Chronic Rhinosinusitis (Diagnosis), Nasal Polyposis | Phase 3 | Terminated | Université de Sherbrooke | 36 | 2017-05-01 | 2022-09-21 |
Nose Diseases (2) · Otorhinolaryngologic Diseases (2) · Pathological Conditions, Anatomical (2) · Pathological Conditions, Signs and Symptoms (2) · Polyps (2) · Respiratory Tract Diseases (2) · Bronchial Diseases (1) · Hypersensitivity (1) · Hypersensitivity, Immediate (1) · Immune System Diseases (1) · Lung Diseases (1) · Lung Diseases, Obstructive (1) · Pathologic Processes (1) · Respiratory Hypersensitivity (1)
Budesonide (1) · benralizumab (1)
AstraZeneca (1) · Université de Sherbrooke (1)
Argentina (1) · Australia (1) · Belgium (1) · Bulgaria (1) · Canada (1) · Chile (1) · China (1) · France (1) · Hungary (1) · Italy (1) · Japan (1) · Poland (1) · Russia (1) · Taiwan (1) · Thailand (1)
2023 (1)